
|Videos|April 15, 2021
Identifying Patients Appropriate for Front Line Maintenance Therapy in Advanced Ovarian Cancer
Author(s)Rebecca Previs, MD
Dr. Rebecca Previs talks about when first line maintenance therapy is appropriate and which patients should be presented with this option.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves RP1/Nivolumab for Progression on Anti–PD-1 Therapy in Melanoma
2
Developers Initiate Phase 2/3 Ivonescimab/EV Trial in Bladder Cancer
3
The Lowest-Ever Hazard Ratio in Multiple Myeloma Bispecific Trials?
4
Why Earlier CAR T-Cell Therapy May Benefit Patients With Multiple Myeloma
5






























































